Science News
from research organizations

Lung cancer: Research validates surgery alone offers reasonable overall survival for stage I SCLC

Date:
February 16, 2010
Source:
International Association for the Study of Lung Cancer
Summary:
A new study investigates the utilization of surgery and the subsequent need for radiotherapy when treating stage I small cell lung cancer. Traditionally, SCLC treatment regimes include chemotherapy and radiotherapy for limited stage disease; however, the study concludes that in selected patients with early stage disease a lobectomy (removal of lung) had an excellent overall survival without additional treatment.
Share:
         
Total shares:  
FULL STORY

Research published in February's edition of the Journal of Thoracic Oncology investigates the utilization of surgery and the subsequent need for radiotherapy (RT) when treating stage I small cell lung cancer (SCLC). Traditionally, SCLC treatment regimes include chemotherapy and radiotherapy for limited stage disease; however, the study concludes that in selected patients with early stage disease a lobectomy (removal of lung) had an excellent overall survival without additional treatment.

Researchers retrospectively evaluated the outcomes of 247 stage I SCLC patients who underwent lobectomies; these cases were identified using the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database. Results showed the three- and five-year survival rates for the patient group who underwent lobectomies without RT were 58.1 percent and 50.3 percent, respectively. For those who supplemented their surgery with RT, three- and five -year overall survival was 64.9 percent and 57.1 percent.

"Based on our analysis, surgery without RT may offer a reasonable survival in a selected cohort of patients who undergo lobectomy, but this needs to be validated in a prospective setting," said study lead investigator James B. Yu, MD, of Yale University. "We cannot say conclusively whether patients who endure invasive surgeries can go without additional adjuvant radiation or chemotherapy, but looking forward, the study findings create a platform for advancing the understanding of the role of surgery in therapy."


Story Source:

The above story is based on materials provided by International Association for the Study of Lung Cancer. Note: Materials may be edited for content and length.


Cite This Page:

International Association for the Study of Lung Cancer. "Lung cancer: Research validates surgery alone offers reasonable overall survival for stage I SCLC." ScienceDaily. ScienceDaily, 16 February 2010. <www.sciencedaily.com/releases/2010/02/100216182029.htm>.
International Association for the Study of Lung Cancer. (2010, February 16). Lung cancer: Research validates surgery alone offers reasonable overall survival for stage I SCLC. ScienceDaily. Retrieved April 25, 2015 from www.sciencedaily.com/releases/2010/02/100216182029.htm
International Association for the Study of Lung Cancer. "Lung cancer: Research validates surgery alone offers reasonable overall survival for stage I SCLC." ScienceDaily. www.sciencedaily.com/releases/2010/02/100216182029.htm (accessed April 25, 2015).

Share This Page:


Health & Medicine News
April 25, 2015

Latest Headlines
updated 12:56 pm ET